- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:24 | Aclarion taps Greg Gould as CFO | 1 | Seeking Alpha | ||
| ACLARION Aktie jetzt für 0€ handeln | |||||
| 12:18 | Aclarion names Greg Gould as new CFO to drive growth strategy | 1 | Investing.com | ||
| 12:06 | Aclarion, Inc.: Aclarion Appoints Greg Gould as Chief Financial Officer | 31 | GlobeNewswire (Europe) | HealthTech CFO with extensive public company experience building organizations for growth and value creation Demonstrated success in raising capital, driving profitability, and scaling operations... ► Artikel lesen | |
| 14.08. | Aclarion, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.08. | Aclarion, Inc.: Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts | 112 | GlobeNewswire (Europe) | Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume... ► Artikel lesen | |
| 21.07. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.07. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.07. | Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
| 25.06. | Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery | - | RTTNews | ||
| 25.06. | Aclarion, Inc.: First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial | 3 | GlobeNewswire (USA) | ||
| 24.06. | Aclarion, Inc.: Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum | 1 | GlobeNewswire (USA) | ||
| 20.06. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | Aclarion, Inc.: Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
| 30.05. | Aclarion stock price target cut to $20 at Ascendiant Capital | 2 | Investing.com | ||
| 30.05. | Kursziel für Aclarion-Aktie von Ascendiant Capital auf 20 US-Dollar gesenkt | 1 | Investing.com Deutsch | ||
| 26.05. | XFRA NEW INSTRUMENTS AVAILABLE ON 26.05.2025 | 554 | Xetra Newsboard | The following instruments on XETRA do have their first trading 26.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 26.05.2025
Aktien
1 MXCFFM010000 Banco Invex S.A.
2... ► Artikel lesen | |
| 20.05. | Aclarion, Inc.: Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site | 9 | GlobeNewswire (USA) | ||
| 15.05. | Aclarion, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.05. | Aclarion, Inc.: Aclarion Announces Texas Back Institute as New CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
| 05.05. | Aclarion, Inc.: Aclarion Welcomes Advocate Health as CLARITY Trial Site | 2 | GlobeNewswire (USA) |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 261,70 | -1,34 % | UnitedHealth: Nicht schon wieder | Am Dienstag gegen US-Handelsende ist die Aktie von UnitedHealth erneut etwas unter Druck geraten. Einmal mehr belastet das Papier des größten Krankenversicherers der USA ein negativer Pressebericht... ► Artikel lesen | |
| INTUITIVE SURGICAL | 386,45 | -4,08 % | ISRG's SP Stapler: A Game Changer for Colorectal and Thoracic Procedures? | ||
| THERMO FISHER | 413,75 | -1,18 % | Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. | Accelerates Solventum's business transformation to deliver long-term shareholder value
Net proceeds will be used primarily to pay down debt
ST. PAUL, Minn.... ► Artikel lesen | |
| ROKU | 83,30 | +1,10 % | TV viewing on Roku-powered devices surpasses broadcast TV for third month in a row | ||
| SERNOVA BIOTHERAPEUTICS | 0,107 | -2,73 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,648 | -1,82 % | RedChip Companies, Inc.: NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 29, 2025 / RedChip Companies will air interviews with NioCorp Developments Ltd. (Nasdaq:NB) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip Small Stocks... ► Artikel lesen | |
| PING AN HEALTHCARE | 2,565 | +11,62 % | HSI Closes at 25,343, Down 153 pts; HSTI Closes at 5,683, Down 44 pts; BYD ELECTRONIC Down over 4%; CSPC PHARMA, CHOW TAI FOOK, MEDBOT-B, PA GOODDOCTOR, WUXI XDC Hit New Highs; Market Turnover Rises | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update | -- Increased Net Sales and Improved Loss from Operations in Q2 2025 vs. Prior Year Quarter --
-- Evofem Advances Plans for Special Meeting of Stockholders to Approve... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,001 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CENTENE | 25,595 | +0,65 % | Are Strategic Contracts and Partnerships Centene's Growth Engine? | ||
| CO-DIAGNOSTICS | 0,280 | +1,45 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| CYTOSORBENTS | 0,820 | -0,49 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
| QUIDELORTHO | 23,800 | -2,46 % | Südkorea will ca. 300 Mio. Euro in neuartige Display-Techniken (Micro LED, QDEL) investieren | ||
| VERU | 3,385 | +3,52 % | VERU INC. - 8-K, Current Report | ||
| FRESENIUS MEDICAL CARE | 41,900 | +0,48 % | Darum fällt der DAX - Außerdem im Fokus: FMC und Deutz | Am Dienstag steht der DAX unter Druck - das belastet den deutschen Leitindex jetzt. Außerdem im Fokus der Börse: die Aktien von FMC und Deutz. Der deutsche Aktienmarkt hat am Dienstag zum Handelsstart... ► Artikel lesen |
Das Unternehmen ACLARION INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,160 (+2,77 %) liegt der Kurs bei 5,940 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACLARION INC finden Sie auf Wallstreet Online.